Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions.
1] Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Department of Haematology, Singapore General Hospital, Singapore, Singapore.
C
C
Phipps
1] Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
M T
MT
Lupo-Stanghellini
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
M E D
ME
Flowers
D061605:Administration, Intravenous; D000328:Adult; D000368:Aged; D000779:Anesthetics, Local / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012594:Scleroderma, Localized / Q000188:drug therapy* / Q000276:immunology
D000779:Anesthetics, Local; D008012:Lidocaine